Rethinking sepsis: from controversy to precision-driven solutions.
作者信息
Upperman Jeffrey, Evans Heather L
机构信息
Pediatric Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Surgical Services, Ralph H. Johnson VA Medical Center, Charleston, South Carolina, USA.
出版信息
Trauma Surg Acute Care Open. 2025 Apr 20;10(2):e001810. doi: 10.1136/tsaco-2025-001810. eCollection 2025.
Abstract
摘要
相似文献
1
Rethinking sepsis: from controversy to precision-driven solutions.重新思考脓毒症：从争议到精准驱动的解决方案。
Trauma Surg Acute Care Open. 2025 Apr 20;10(2):e001810. doi: 10.1136/tsaco-2025-001810. eCollection 2025.
2
Sepsis and mediator-directed therapy: rethinking the target populations. Mediator-directed therapy in sepsis: rethinking the target populations. Toronto, Canada, 31 October-1 November 1998.脓毒症与介质导向治疗：对目标人群的重新思考。脓毒症中的介质导向治疗：对目标人群的重新思考。1998年10月31日至11月1日于加拿大多伦多
Mol Med Today. 1999 Feb;5(2):56-8. doi: 10.1016/s1357-4310(98)01413-0.
3
Editorial: Rethinking the definition of diabetes for precision medicine.社论：为精准医学重新思考糖尿病的定义
Mol Endocrinol. 2015 Mar;29(3):335-7. doi: 10.1210/me.2015-1037.
4
Editorial Comment: Recovery from Extreme Hemodilution (Hemoglobin Level of 0.6 g/dL) in Cadaveric Liver Transplantation and Management of a Jehovah's Witness Patient with Sepsis and Profuse Bleeding After Emergency Coronary Artery Bypass Graft Surgery: Rethinking the Critical Threshold of Oxygen Delivery.
A A Case Rep. 2015 May 15;4(10):137-9. doi: 10.1213/XAA.0000000000000153.
5
Rethinking sepsis after a two-year battle with COVID-19.在与新冠病毒斗争两年后对脓毒症的重新思考。
Cell Mol Immunol. 2022 Nov;19(11):1317-1318. doi: 10.1038/s41423-022-00909-7. Epub 2022 Sep 1.
6
Sepsis subphenotypes: bridging the gaps in sepsis treatment strategies.脓毒症亚表型：弥合脓毒症治疗策略的差距
Front Immunol. 2025 Feb 6;16:1546474. doi: 10.3389/fimmu.2025.1546474. eCollection 2025.
7
Current clinical controversies in the management of sepsis.
J R Coll Physicians Edinb. 2016 Dec;46(4):263-269. doi: 10.4997/JRCPE.2016.413.
8
Clinical trial research in focus: rethinking trials in sepsis.聚焦临床试验研究：重新思考脓毒症试验
Lancet Respir Med. 2017 Aug;5(8):610-611. doi: 10.1016/S2213-2600(17)30268-0.
9
Rethinking management of neonates at risk of sepsis.重新思考有败血症风险新生儿的管理
Lancet. 2019 Jul 27;394(10195):279-281. doi: 10.1016/S0140-6736(19)31627-7.
10
The surviving sepsis controversy: a call to action for hospital medicine.存活脓毒症争议：医院医学的行动呼吁。
Expert Rev Anti Infect Ther. 2018 Dec;16(12):889-892. doi: 10.1080/14787210.2018.1547192. Epub 2018 Nov 14.
本文引用的文献
1
Unpacking the sepsis controversy.剖析脓毒症争议
Trauma Surg Acute Care Open. 2025 Mar 4;10(1):e001733. doi: 10.1136/tsaco-2024-001733. eCollection 2025.
2
From rare to more common: The emerging role of omics in improving understanding and treatment of severe inflammatory and hyperinflammatory conditions.从罕见到更常见：组学在增进对严重炎症和高炎症状态的理解及治疗方面的新作用
J Allergy Clin Immunol. 2025 May;155(5):1435-1450. doi: 10.1016/j.jaci.2025.02.011. Epub 2025 Feb 18.
3
Harnessing artificial intelligence in sepsis care: advances in early detection, personalized treatment, and real-time monitoring.脓毒症护理中人工智能的应用：早期检测、个性化治疗和实时监测的进展
Front Med (Lausanne). 2025 Jan 6;11:1510792. doi: 10.3389/fmed.2024.1510792. eCollection 2024.
4
The pathophysiology of sepsis and precision-medicine-based immunotherapy.脓毒症的病理生理学与基于精准医学的免疫治疗。
Nat Immunol. 2024 Jan;25(1):19-28. doi: 10.1038/s41590-023-01660-5. Epub 2024 Jan 2.
5
Profiling the dysregulated immune response in sepsis: overcoming challenges to achieve the goal of precision medicine.剖析脓毒症中失调的免疫反应：克服挑战，实现精准医学目标。
Lancet Respir Med. 2024 Apr;12(4):305-322. doi: 10.1016/S2213-2600(23)00330-2. Epub 2023 Dec 21.
6
Global health systems' data science approach for precision diagnosis of sepsis in early life.全球卫生系统采用数据科学方法对早期脓毒症进行精准诊断。
Lancet Infect Dis. 2022 May;22(5):e143-e152. doi: 10.1016/S1473-3099(21)00645-9. Epub 2021 Dec 13.
Zotero 插件